Progressive Corp reports September 2026 financial results
Progressive Corp releases financial results for September 2026, showcasing strong performance in the fire, marine, and casualty insurance sector.
Oncolytics Biotech expects final PanCAN grant payment
Oncolytics Biotech Inc. anticipates receiving the final grant payment from PanCAN as it concludes enrollment in the GOBLET study, with more clinical data to follow.
Ultragenyx sells Rare Pediatric Disease Priority Review Voucher
Ultragenyx Pharmaceutical Inc. sells a Rare Pediatric Disease Priority Review Voucher for $203 million, enhancing its financial strength in the pharmaceutical industry.
Vir Biotechnology and Gilead Sciences Announce Collaboration
Vir Biotechnology partners with Gilead Sciences for T-cell engager development, enhancing its oncology portfolio and expanding industry innovation.
Pulse Biosciences Partners with Clayman Thyroid Center
Pulse Biosciences announces a partnership with the Clayman Thyroid Center to enhance patient care and generate clinical data for its nPulse Vybrance System.
Strive, Inc. Reports $369.2M from Warrant Exercises, Bitcoin Buy
Strive, Inc. announces $369.2 million from warrant exercises and a bitcoin purchase, indicating strong liquidity and strategic investment in crypto assets.
OneMedNet Regains Compliance with Nasdaq Listing Rules
OneMedNet Corp has regained compliance with Nasdaq's minimum bid price requirement, ensuring its continued listing on the Nasdaq Capital Market.
Coya Therapeutics to Initiate Open-Label Extension for ALS Trial
Coya Therapeutics announces plans for an open-label extension of its ALS trial for COYA 302, responding to participant requests for continued treatment.
Data443 launches Vaikora, AI enforcement platform
Data443 Risk Mitigation, Inc. announces the launch of Vaikora, an AI runtime enforcement platform, enhancing its position in the prepackaged software sector.
Fermi Inc. Secures $6.5B Lease with TensorWave for 15 Years
Fermi Inc. announces a $6.5 billion lease agreement with TensorWave, enhancing its position in the Real Estate Investment Trusts sector.
Eagle Point Income Co Reports Significant Operational Update
Eagle Point Income Co files an 8-K detailing recent operational updates that could impact its strategy and the investment management industry.
Aptevo Therapeutics to Present at SITC Annual Meeting 2026
Aptevo Therapeutics Inc. will showcase its multispecific platform at the SITC Annual Meeting from November 4-8, 2026, in Phoenix, Arizona.
Entrada Therapeutics Reports Positive Results in DMD Study
Entrada Therapeutics announces positive topline results from its Phase 1/2 ELEVATE-45-201 study of ENTR-601-45 for Duchenne muscular dystrophy.
Eagle Point Credit Co reports Q3 estimates for NAV, income
Eagle Point Credit Co estimates Q3 net asset value and income per share. The company projects NAV between $4.12 and $4.22.
Nordicus Partners Corp Secures $75,000 Promissory Note
Nordicus Partners Corp has secured a $75,000 promissory note to enhance working capital, marking a significant move in management consulting services.
MaxCyte Reports Strong Q3 Results, Raises Revenue Guidance
MaxCyte, Inc. announces a 26% increase in Q3 revenue and raises its 2026 revenue guidance. The company continues to grow in the cell therapy market.
WhiteHorse Finance announces special distribution, Q3 results date
WhiteHorse Finance, Inc. reveals a special distribution and the date for its Q3 financial results, signaling a commitment to shareholder returns.
Datacentrex Announces Installation of 500 ASIC Miners
Datacentrex, Inc. begins installation of over 500 ASIC miners, enhancing its operations in the computer processing industry.
Brightline Interactive Regains Nasdaq Compliance with Bid Price
Brightline Interactive, Inc. has regained compliance with Nasdaq's minimum bid price requirement, enhancing investor confidence and market stability.
Fastenal Reports Strong Third Quarter Earnings Growth
Fastenal Co announces a 15.5% increase in daily sales for Q3 2026, driven by strong demand and customer gains.